Search

Search Constraints

You searched for: Author/Creator Rouvio, Ory

Search Results

1. Clinical features, therapy patterns, outcomes and prognostic factors of solitary plasmacytomas: a report of the Israeli Myeloma Study Group. Issue 14 (6th December 2022)

2. Daratumumab for relapsed AL amyloidosis—When cumulative real‐world data precedes clinical trials: A multisite study and systematic literature review. (9th November 2020)

3. Daratumumab for relapsed AL amyloidosis—When cumulative real‐world data precedes clinical trials: A multisite study and systematic literature review. (9th November 2020)

4. Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study. (16th November 2015)

5. Incidence rates and clinical characteristics of primary gastrointestinal non-Hodgkin lymphoma: a population study. Issue 5 (May 2020)

6. Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study. Issue 2 (24th January 2013)

7. Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia. (July 2019)

8. Primary plasma cell leukemia in the era of novel agents for myeloma – a multicenter retrospective analysis of outcome. (May 2018)